Lim SS, Davies MJ, Norman RJ, Moran LJ (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
A Conceptual Model of Food Cue Reactivity - PMC - PubMed Central, accessed April 22, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 22, 2025, GLP-1 and the Neurobiology of Eating Control: Recent Advances - Oxford Academic, accessed April 22, 2025, pmc.ncbi.nlm.nih.gov, accessed April 22, 2025, Taking a GLP-1
This is another important benefit of GLP-1s, as kidney disease is a common complication of diabetes
What FDA's Public Guidance on Compounded GLP-1 Products Says - and How Consumers Can Use It as a Due-Diligence Framework FDA has publicly identified concerns involving unapproved and compounded GLP-1 products